Samsung continues an agreement formerly signed with Glenmark to manufacture Ichnos’ mAb treatment candidate for atopic dermatitis, as the product enters Phase III clinical trials.
SGS’ completed the ₤8.7m expansion of its large molecule testing facility in Glasgow and made room to increase its existing biosafety service and PCR platform capabilities.
I-Mab and WuXi Biologics extend their strategic partnership for biologics process development as well as clinical and commercial manufacturing to accelerate drug development in China and abroad.
Shantha Biotechnics is planning clinical trials for a new lung
cancer therapy, which could prove to be the first time an Indian
company has conducted a trial in the US.
CureTech has revealed it has wrapped up a deal in which Teva
Pharmaceuticals will invest $6m (€4.7m) in CureTech, for the
development of a revolutionary cancer drug, based on the company's
potential value of $64m.
Contract biomanufacturing firm Laureate has won a contract to
produce Seattle Genetics' humanised monoclonal antibody product
candidates for clinical trial, adding to its experience in
monoclonal antibody development.
The drug trial catastrophe, which has endangered the lives of six
male volunteers of which two are still in a coma, could've been
avoided after a similar study conducted last year yielded similar
side effects.
The worldwide market for therapeutic and diagnostic monoclonal
antibodies is expected to reach $26 million (€21.2 million) by
2010, buoyed on by technological advances that allow antibodies to
exhibit a specified targeted attack on...
GE Healthcare announced the launch of two new purification tools
designed to meet growing industry needs for the advancement of
monoclonal antibody (MAbs) research and development. The tools
become the latest offering in the chromatography...
